SEI Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $131M | Sell |
1,034,568
-123,531
| -11% | -$16.3M | 0.12% | 183 |
|
|
2026
Q1 | $161M | Buy |
1,158,099
+65,384
| +6% | +$9.16M | 0.15% | 131 |
|
|
2025
Q4 | $134M | Sell |
1,092,715
-159,299
| -13% | -$19.4M | 0.13% | 145 |
|
|
2025
Q3 | $139M | Buy |
1,252,014
+310,406
| +33% | +$35.3M | 0.15% | 132 |
|
|
2025
Q2 | $104M | Buy |
941,608
+92,945
| +11% | +$9.89M | 0.12% | 171 |
|
|
2025
Q1 | $95.1M | Buy |
848,663
+88,305
| +12% | +$9.11M | 0.12% | 170 |
|
|
2024
Q4 | $70.2M | Buy |
760,358
+116,530
| +18% | +$10.5M | 0.09% | 235 |
|
|
2024
Q3 | $54M | Buy |
643,828
+39,847
| +7% | +$3.04M | 0.07% | 303 |
|
|
2024
Q2 | $41.4M | Sell |
603,981
-101,229
| -14% | -$6.76M | 0.06% | 346 |
|
|
2024
Q1 | $51.7M | Sell |
705,210
-126,029
| -15% | -$9.69M | 0.08% | 281 |
|
|
2023
Q4 | $67.3M | Sell |
831,239
-24,189
| -3% | -$1.88M | 0.11% | 191 |
|
|
2023
Q3 | $64.1M | Sell |
855,428
-24,430
| -3% | -$1.88M | 0.12% | 163 |
|
|
2023
Q2 | $67.8M | Sell |
879,858
-9,089
| -1% | -$725K | 0.12% | 153 |
|
|
2023
Q1 | $73.8M | Buy |
888,947
+66,287
| +8% | +$5.49M | 0.14% | 134 |
|
|
2022
Q4 | $70.6M | Buy |
822,660
+131,753
| +19% | +$10.4M | 0.16% | 117 |
|
|
2022
Q3 | $42.6M | Buy |
690,907
+92,657
| +15% | +$5.84M | 0.1% | 226 |
|
|
2022
Q2 | $36.9M | Sell |
598,250
-83,048
| -12% | -$5.14M | 0.08% | 277 |
|
|
2022
Q1 | $40.5M | Sell |
681,298
-496
| -0.1% | -$31.7K | 0.08% | 255 |
|
|
2021
Q4 | $49.6M | Sell |
681,794
-93,216
| -12% | -$6.42M | 0.09% | 224 |
|
|
2021
Q3 | $54.2M | Buy |
775,010
+226,785
| +41% | +$15.9M | 0.11% | 188 |
|
|
2021
Q2 | $37.8M | Buy |
548,225
+205,534
| +60% | +$13.7M | 0.08% | 240 |
|
|
2021
Q1 | $21.6M | Buy |
342,691
+32,044
| +10% | +$2.07M | 0.05% | 356 |
|
|
2020
Q4 | $18.1M | Sell |
310,647
-4,999
| -2% | -$302K | 0.05% | 389 |
|
|
2020
Q3 | $20M | Sell |
315,646
-46,689
| -13% | -$3.24M | 0.06% | 314 |
|
|
2020
Q2 | $27.9M | Buy |
362,335
+9,485
| +3% | +$727K | 0.09% | 222 |
|
|
2020
Q1 | $26.5M | Sell |
352,850
-38,365
| -10% | -$2.65M | 0.1% | 194 |
|
|
2019
Q4 | $25.5M | Buy |
391,215
+25,840
| +7% | +$1.68M | 0.08% | 255 |
|
|
2019
Q3 | $23.4M | Buy |
365,375
+20,310
| +6% | +$1.33M | 0.06% | 300 |
|
|
2019
Q2 | $23.5M | Buy |
345,065
+20,409
| +6% | +$1.34M | 0.08% | 269 |
|
|
2019
Q1 | $21.3M | Buy |
324,656
+20,346
| +7% | +$1.35M | 0.07% | 282 |
|
|
2018
Q4 | $22.6M | Buy |
304,310
+43,986
| +17% | +$3.07M | 0.08% | 246 |
|
|
2018
Q3 | $20.1M | Sell |
260,324
-147,483
| -36% | -$11.1M | 0.07% | 269 |
|
|
2018
Q2 | $28.9M | Buy |
407,807
+105,146
| +35% | +$7.43M | 0.1% | 195 |
|
|
2018
Q1 | $22.8M | Sell |
302,661
-110,624
| -27% | -$8.79M | 0.09% | 234 |
|
|
2017
Q4 | $29.6M | Buy |
413,285
+52,392
| +15% | +$3.98M | 0.1% | 201 |
|
|
2017
Q3 | $29.2M | Buy |
360,893
+130,718
| +57% | +$10M | 0.1% | 196 |
|
|
2017
Q2 | $16.3M | Sell |
230,175
-148,200
| -39% | -$9.86M | 0.06% | 357 |
|
|
2017
Q1 | $25.7M | Sell |
378,375
-2,403
| -0.6% | -$169K | 0.11% | 198 |
|
|
2016
Q4 | $27.3M | Buy |
380,778
+43,737
| +13% | +$3.25M | 0.13% | 166 |
|
|
2016
Q3 | $26.7M | Buy |
337,041
+73,807
| +28% | +$6M | 0.14% | 174 |
|
|
2016
Q2 | $22M | Sell |
263,234
-179,187
| -41% | -$15.9M | 0.13% | 193 |
|
|
2016
Q1 | $40.6M | Sell |
442,421
-139,659
| -24% | -$12.6M | 0.25% | 97 |
|
|
2015
Q4 | $58.9M | Buy |
582,080
+136,343
| +31% | +$14.2M | 0.36% | 45 |
|
|
2015
Q3 | $43.8M | Sell |
445,737
-116,015
| -21% | -$12.9M | 0.4% | 43 |
|
|
2015
Q2 | $65.8M | Sell |
561,752
-52,283
| -9% | -$5.71M | 0.59% | 24 |
|
|
2015
Q1 | $60.3M | Sell |
614,035
-112,938
| -16% | -$11.5M | 0.52% | 23 |
|
|
2014
Q4 | $68.5M | Buy |
+726,973
| New | +$75.2M | 0.61% | 22 |
|
Other funds holding GILD
SEI Investments's GILD Position: Q2 2026 in Review
SEI Investments reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $16.3M and leaving 1,034,568 shares worth $131M. The position accounts for 0.12% of the portfolio, ranked #183.
SEI Investments first reported a position in GILD in Q4 2014 and has held it in 47 quarters since. The position peaked at $161M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- SEI Investments held 1,034,568 shares of Gilead Sciences worth $131M as of Q2 2026.
- SEI Investments sold 123,531 Gilead Sciences shares in Q2 2026, an estimated $16.3M.
- Gilead Sciences made up 0.12% of SEI Investments's portfolio in Q2 2026, its #183 holding.
- SEI Investments first reported a position in Gilead Sciences in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's Gilead Sciences position peaked at $161M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.